Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.

The petition titled 'Introduce a screening programme for prostate cancer, starting with high-risk men' has currently drawn in over 44,000 signatures. Should it reach 100,000, it will be considered for ...

The Government has issued an important statement on prostate cancer and the potential for a screening programme, starting with high-risk men. Its message responds to an ongoing parliamentary petition ...

Using both PSMA PET and mpMRI before cognitive targeted biopsy improved specificity for clinically significant prostate cancer from 54.6% to 86.3%. For men undergoing evaluation for suspected prostate ...

In a biopsy, a small sample of tissue is taken from your body. A pathologist analyzes the sample to check for cancer cells. The main method for diagnosing prostate cancer is a core needle biopsy. It’s ...